The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects
Open accessAbstract
Background: Electronic “cigarettes” are marketed to tobacco users as potential reduced exposure products (PREP), albeit with little information regarding electronic cigarette user toxicant exposure and effects. This information may be obtained by adapting clinical laboratory methods used to evaluate other PREPs for smokers. Methods: Thirty-two smokers participated in four independent Latin-square ordered conditions that differed by product: own brand cigarette, “NPRO” electronic cigarettes (NPRO EC; 18 mg cartridge), “Hydro” electronic cigarettes (Hydro EC; 16 mg cartridge), or sham (unlit cigarette). Participants took 10 puffs at two separate times during each session. Plasma nicotine and carbon monoxide (CO) concentration, heart rate, and subjective effects were assessed. Results: Own brand significantly increased plasma nicotine and CO concentration and heart rate within the first five minutes of administration whereas NPRO EC, Hydro EC, and sham smoking did not. Own brand, NPRO EC, and Hydro EC (but not sham) significantly decreased tobacco abstinence symptom ratings and increased product acceptability ratings. The magnitude of symptom suppression and increased acceptability was greater for own brand than for NPRO EC and Hydro EC. Conclusions: Under these acute testing conditions, neither of the electronic cigarettes exposed users to measurable levels of nicotine or CO, although both suppressed nicotine/tobacco abstinence symptom ratings. Impact: This study illustrates how clinical laboratory methods can be used to understand the acute effects of these and other PREPs for tobacco users. The results and methods reported here will likely be relevant to the evaluation and empirically based regulation of electronic cigarettes and similar products. Cancer Epidemiol Biomarkers Prev; 19(8); 1945–53. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 186
Pharmacokinetics and pharmacodynamics of moist snuff in humans
Fant, R. V., Henningfield, J. E., Nelson, R. A., & Pickworth, W. B. (1999) · Tobacco Control · doi:10.1136/tc.8.4.387 · Cited by 156
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers
Gourlay, S. G., Forbes, A., Forbes, A., Marriner, T., Pethica, D., & McNeil, J. J. (1995) · BMJ · doi:10.1136/bmj.311.7001.363 · Cited by 104
Cobb, C. O., Weaver, M. F., & Eissenberg, T. (2010) · Tobacco Control · doi:10.1136/tc.2008.028993 · Cited by 45
Self-citation
Cited by
E-Cigarettes: A Scientific Review
Grana, R., Benowitz, N., & Glantz, S. A. (2014) · Circulation · doi:10.1161/circulationaha.114.007667 · Cited by 1,194
“If this is the case, the nonnicotine placebo e-cigarette would be considered an active treatment condition and, as discussed previously, has been shown to reduce withdrawal symptoms.(59,60,63,89) Important limitations of the current research include the use of e-cigarettes that deliver relatively low levels of nicotin…”
Etter, J.-F., & Bullen, C. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03505.x · Cited by 677
Hajek, P., Etter, J., Benowitz, N., Eissenberg, T., & McRobbie, H. (2014) · Addiction · doi:10.1111/add.12659 · Cited by 546
Self-citationShort-term Pulmonary Effects of Using an Electronic Cigarette
Vardavas, C. I., Anagnostopoulos, N., Kougias, M., Evangelopoulou, V., Connolly, G. N., & Behrakis, P. K. (2012) · Chest · doi:10.1378/chest.11-2443 · Cited by 532
Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA
Regan, A. K., Promoff, G., Dube, S. R., & Arrazola, R. (2013) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050044 · Cited by 490
Metadata
- Authors
- Vansickel, A. R., Cobb, C. O., Weaver, M. F., & Eissenberg, T. E.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2010-08-01
- Volume
- 19
- Issue
- 8
- Pages
- 1945-1953
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2106457238
- Cited by
- 380
- References
- 4
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects. https://app.cochat.ai/papers/10.1158/1055-9965.epi-10-0288
- The paper
- Vansickel, A. R., Cobb, C. O., Weaver, M. F., & Eissenberg, T. E. (2010). A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-10-0288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.